Work

Mechanisms of neurodegeneration in transgenic models of Huntington's disease

Year: 2007
Type: dissertation
Abstract: Huntington’s disease (HD) is a devastating neurodegenerative disorder caused by an expanded CAG repeat in the IT15 gene, which encodes for huntingtin. The disease is classically characterized by accumulation of huntingtin in neuronal intranuclear inclusions, a progressive degeneration of neurons in the striatum and the cerebral cortex, which leads to progressive motor and cognitive deterioration, and inevitably death. Since the discovery of the mutation responsible for HD, several transgenic rodent models have been generated. The most widely studied are the R6 lines that express exon 1 of the IT15 gene with 115 (R6/1) or 145 (R6/2) CAG repeats. The work presented in this thesis further characterizes these transgenic HD rodent models (particularly the R6 mice) and describes, for the first time, a number of novel histological and functional changes in HD. The first part of this thesis evaluates changes in neurotransmitter systems, at the level of glutamate receptor stimulation (Chapter 2) and dopamine (DA) release (Chapter 3). More precisely, the work presented in Chapter 2 demonstrates that, unlike R6 mice that are known to be resistant to excitotoxic insults, a newly generated HD transgenic rat (which expresses 22% of the IT15 gene with 51 CAG repeats) is not resistant to this damage. These results, together with previous research, suggest that the response of transgenic HD rodent models to excitotoxicity is dependent on the length of the transgene expressed. On the other hand, Chapter 3 describes an impairment in the release of DA in R6/1 mice, as determined by in vivo microdialysis upon membrane depolarization-induced exocytosis and DA transporter-mediated efflux. In support of this result, a reduction in whole striatal DA levels and basal levels of DA metabolites were also observed. These results suggest a dysfunction of the dopaminergic nigrostriatal pathway in HD. The second part of this thesis explores the involvement of nonstriatal brain regions, namely the lateral hypothalamus (Chapter 4) and the dentate gyrus (DG) of the hippocampus (Chapters 5 and 6), in the neuropathology of the R6/2 HD mouse. Chapter 4 describes, for the first time, loss of specific neuronal populations in the lateral hypothalamus of R6/2 mice. Two major neuronal populations were affected: orexin-containing neurons (which regulate the sleep/wakefulness cycle) and melanin-concentrating hormone-containing neurons (which play a role in maintaining energy homeostasis). Importantly, the progressive loss of orexin neurons was accompanied by the development of narcoleptic-like symptoms in R6/2 mice, which closely resemble the deficits reported in orexin knockout mice by other researchers. In conjunction with the loss of these neurons we also observed decreased levels of orexin in the cerebrospinal fluid of end-stage R6/2 mice. Interestingly, we also found loss of orexin neurons in samples of the lateral hypothalamus of HD patients. Overall, these results clearly implicate the lateral hypothalamus in the pathology of HD. Finally, Chapters 5 and 6 describe, for the first time, a dysfunction in yet another nonstriatal brain region, the DG of the hippocampus, in R6/2 mice. The DG constitutes one of the regions in the adult mammalian brain where neurogenesis (i.e., generation of new neurons) occurs. R6/2 mice show a progressive decrease in the number of proliferating cells and neurons in the DG when compared to wild-type littermate controls. Moreover, this decrease can be detected as early as 2 weeks of age, when the R6/2 mice do not show any clear behavioral symptoms. Finally, treating the R6/2 mice with asialoerythropoietin (an erythropoietin analogue) did not reverse the decreased rate of neurogenesis nor had any effect on the neuropathology or the development of motor symptoms. Overall, the results presented in this thesis provide new evidence that corroborates the implication of excitotoxicity and dopaminergic dysfunction in the HD striatum. It also demonstrates pathological changes and morphological dysfunction in nonstriatal structures, such as the lateral hypothalamus and the DG of the hippocmapus. Moreover, this data further contributes to our understanding of the transgenic rodent models used in HD research by expanding our knowledge of their neuropathology. We speculate that this work may be instrumental in the design and screening of new therapies to treat this devastating neurodegenerative disorder.
Language: English
Open Access status: green
OpenAlex ID: W2596885315
Cites: 319
Cited by:
Related to: 10